2nd Priority Review Voucher Summit (EXL)
Event on 2017-10-26 08:00:00
2nd Priority Review Voucher Summit
The FDA’s Priority Review Voucher Programs are incentives meant to encourage the development of new treatments for diseases that lack commercial viability and do not typically garner development interest from companies. These incentives come in the form of special vouchers, which allow a company to have any one of their future drugs reviewed under the FDA’s priority review system.
The priority review process can be extremely beneficial for companies and patients. A quicker review process allows patients with serious conditions to gain access to potentially life-saving or -changing treatments. It also allows companies to market their product sooner and begin recouping their considerable development costs. Additionally, there is the option to sell a PRV, which can help offset development costs. A number of priority review vouchers have been sold to other drug sponsors for prices ranging from .5 million to 0 million, which has helped incentivize research for treatments of neglected tropical and rare pediatric diseases.
The 2nd Priority Review Voucher Summit is the leading event to understand the benefits and challenges of developing a drug that would be eligible for a PRV, and will provide attendees with the opportunity to network and engage with leaders from pharmaceutical companies, social enterprises, patient groups, government agencies and the investment community to create the best development strategy for your organization/portfolio.
Top Five Reasons to Attend
Understand the various priority review voucher programs and their respective eligibility requirements
Navigate the changing regulatory landscape and effectively anticipate the future of the program
Discuss the various valuation models to utilize before buying or selling a priority review voucher
Examine the challenges of clinical study design, operational logistics and patient engagement for developing rare disease therapeutics
Comply with regulatory requirements by composing and submitting compliant documentation
Who Should Attend
Professionals in biotech and pharmaceutical companies with responsibilities in the following areas:
Rare/Orphan Program Management
This event is also of interest to:
Venture Capitalist/Private Equity/Financial Organizations
Drug Development Service Providers
MEDtube is an innovative video education platform for health professionals. It allows sharing videos and other materials with a community of more than 110,000 users worldwide, as well as building e-learning courses. The videoteque is updated daily and now contains almost 15,000 videos.
PharmaLeaders.com is an online environment dedicated to enriching the careers of more than 200,000 life sciences professionals. With breaking news and informative content grouped into one of nine segmented channels, in-depth special reports, job and events postings, and so much more, industry executives, manufacturers, marketers and educators can count on PharmaLeaders for the tools they need to succeed in today’s competitive market environment.
pharmaphorum drives innovation within the pharmaceutical industry, by bringing together healthcare through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.
PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the ‘360’ in our title signifies the combination of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas.
Please contact the event manager Marilyn below for the following:
– Discounts for registering 5 or more participants.
– If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.
This Event Listing is Promoted by
New York Media Technologies LLC in association
with EXL Events Inc.
at Hyatt Regency Boston Harbor
101 Harborside Drive
Boston, United States